Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Arbab, Ali S ^a   Janic, Branislava ^a   Jafari Khouzani, Kourosh ^a   Iskander, A S M ^a   Kumar, Sanath ^a   Varma, Nadimpalli R S ^a   Knight, Robert A ^a   Soltanian Zadeh, Hamid ^a   Brown, Stephen L ^a   Frank, Joseph A ^b,c  

^a HENRY FORD HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL LABELING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; GLIOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION INJURY; RADIATION NECROSIS; RAT; UMBILICAL CORD BLOOD; VACCINATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BRAIN TUMOR; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DRUG SCREENING; FETUS BLOOD; HUMAN; IMMUNOLOGY; MAGNETISM; METHODOLOGY; NEOPLASM; PATHOLOGY; RADIATION INDUCED NEOPLASM; RADIOTHERAPY; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALIA; RATTUS; RODENTIA;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; BRAIN NEOPLASMS; CELL LINE, TUMOR; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; FETAL BLOOD; GLIOMA; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MAGNETIC RESONANCE IMAGING; MAGNETICS; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; RATS; T-LYMPHOCYTES, CYTOTOXIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77949725948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009365     Document Type: Article

References (52)

1. Remer S, Murphy ME (2004) The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs 8: 368-376.
2. Iwama T, Yamada H, Sakai N, Andoh T, Nakashima T, et al. (1991) Correlation between magnetic resonance imaging and histopathology of intracranial glioma. Neurol Res 13: 48-54.
3. Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34: 463-469.
4. Dhermain F, Ducreux D, Bidault F, Bruna A, Parker F, et al. (2005) [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma]. Bull Cancer 92: 333-342.
5. Chang SM, Butowski NA, Sneed PK, Garner IV (2006) Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. Neurosurg Focus 20: E4.
6. Hentschel SJ, Sawaya R (2003) Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 10: 109-114.
7. Phuphanich S, Jacobs M, Murtagh FR, Gonzalvo A (1996) MRI of spinal cord radiation necrosis simulating recurrent cervical cord astrocytoma and syringomyelia. Surg Neurol 45: 362-365.
8. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, et al. (1986) Brain radiation lesions: MR imaging. Radiology 158: 149-155.
9. Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, et al. (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54: 1111-1117; discussion; 1117-1119.
10. Hein PA, Eskey CJ, Dunn JF, Hug EB (2004) Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25: 201-209.
11. Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH (1987) Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11: 563-570.
12. Buchpiguel CA, Alavi JB, Alavi A, Kenyon LC (1995) PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 36: 159-164.
13. Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, et al. (1992) Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12: 269-279.
14. Wurker M, Herholz K, Voges J, Pietrzyk U, Treuer H, et al. (1996) Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med 23: 583-586.
15. Yamanaka R, Abe T, Yajima N, Tsuchiya N, Homma J, et al. (2003) Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer 89: 1172-1179.
16. Yamanaka R, Yajima N, Abe T, Tsuchiya N, Homma J, et al. (2003) Dendritic cell-based glioma immunotherapy (review). Int J Oncol 23: 5-15.
17. Arbab AS, Rad AM, Iskander AS, Jafari-Khouzani K, Brown SL, et al. (2007) Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study. Magn Reson Med 58: 519-526.
18. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, et al. (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.[see comment]. Blood 104: 1217-1223.
19. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, et al. (2003) Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 76: 1123-1130.
20. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, et al. (2004) Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Molecular Imaging: Official Journal of the Society for Molecular Imaging 3: 24-32.
21. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, et al. (2005) Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105: 420-425.
22. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, et al. (2004) Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Annals of Neurology 55: 654-659.
23. Arbab AS, Frenkel V, Pandit SD, Anderson SA, Yocum GT, et al. (2006) Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24: 671-678. Epub 2005 Sep 2022.
24. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, et al. (2004) In vivo trafficking and targeted delivery of magnetically labeled stem cells. Human Gene Therapy 15: 351-360.
25. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, et al. (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99: 16267-16272. Epub 12002 Nov 16220.
26. Arbab AS, Yocum GT, Kalish H, Jordan EJ, Anderson SA, et al. (2004) Ferumoxides-protamine sulfate labeling does not alter differentiation of mesenchymal stem cells. Blood 104: 3412-3413.
27. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, et al. (2005) Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18: 553-559.
28. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, et al. (2003) In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic Tlymphocyte trafficking to tumors. Cancer Res 63: 6838-6846.
29. Daldrup-Link HE, Meier R, Rudelius M, Piontek G, Piert M, et al. (2005) In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 15: 4-13.
30. Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, et al. (2009) Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 6: 53-58.
31. Lazovic J, Jensen MC, Ferkassian E, Aguilar B, Raubitschek A, et al. (2008) Imaging Immune Response In vivo: Cytolytic Action of Genetically Altered T Cells Directed to Glioblastoma Multiforme. Clin Cancer Res 14: 3832-3839.
32. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299-308.
33. Agger R, Petersen MS, Petersen CC, Hansen SB, Stodkilde-Jorgensen H, et al. (2007) T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J Immunother 30: 29-39.
34. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, et al. (2009) Gene therapy with human and mouse T cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood.
35. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, et al. (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61: 842-847.
36. Yu JS, Liu G, Ying H, Yong WH, Black KL, et al. (2004) Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64: 4973-4979.
37. Fields RC, Shimizu K, Mule JJ (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A 95: 9482-9487.
38. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, et al. (2009) Optimization and validation of FePro cell labeling method. PLoS One 4: e5873.
39. Dahnke H, Liu W, Herzka D, Frank JA, Schaeffter T (2008) Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med 60: 595-603.
40. Liu W, Dahnke H, Jordan EK, Schaeffter T, Frank JA (2008) In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed 21: 242-250.
41. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. : - Nat Biotechnol 23: 1407-1413.Epub 2005 Oct 1430.
42. Zhu J, Zhou L, XingWu F (2006) Tracking neural stem cells in patients with brain trauma. N Engl J Med 355: 2376-2378.
43. Callera F, de Melo CM (2007) Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev 16: 461-466.
44. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, et al. (2008) Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 8: 701-706.
45. Izumiyama H, Abe T, Tanioka D, Fukuda A, Kunii N (2004) Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background. Brain Tumor Pathol 21: 39-46.
46. Nelson SJ (2003) Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther 2: 497-507.
47. Rad A, Iskander A, Janic B, Knight R, Arbab A, et al. (2009) AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study. BMC Biotechnology 9: 28.
48. Bolus NE, George R, Washington J, Newcomer BR (2009) PET/MRI: The Blended-Modality Choice of the Future? J Nucl Med Technol 37: 63-71.
49. Tada Y, J OW, Yu L, Shimozato O, Wang YQ, et al. (2003) T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines. Cancer Gene Ther 10: 451-456.
50. Rad AM, Janic B, Iskander A, Soltanian-Zadeh H, Arbab AS (2007) Measurement of quantity of iron in magnetically labeled cells: comparison among different UV/VIS spectrometric methods Biotechniques 43: 627-636.
51. Kim JH, Khil MS, Kolozsvary A, Gutierrez JA, Brown SL (1999) Fractionated radiosurgery for 9L gliosarcoma in the rat brain. International Journal of Radiation Oncology, Biology, Physics 45: 1035-1040.
52. Munter MW, Karger CP, Reith W, Schneider HM, Peschke P, et al. (1999) Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. Radiology 212: 475-482.